- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03914937
Virtual Reality in Plastic Surgery: Pain Control and Augmented Satisfaction
August 20, 2024 updated by: The Guthrie Clinic
The study is looking at whether wearing a virtual reality device will help reduce pain and anxiety during minor procedures
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Patients who are undergoing minor plastic surgery procedures will be assigned to either wear a virtual reality device or to listen to music of their choice.
Patients will still get the standard lidocaine/novocaine numbing agent.
Patients will be asked questions about their anxiety level and pain level.
Heart rate and blood pressure will be monitored as measures of anxiety and pain.
Study Type
Observational
Enrollment (Actual)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Sayre, Pennsylvania, United States, 18840
- Robert Packer Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Patients scheduled for minor elective plastic surgery procedure
Description
Inclusion Criteria:
- Patients scheduled for minor elective plastic surgery procedure
- Patients without cognitive, visual or hearing impairments
Exclusion Criteria:
- Patients with conditions that may prohibit participation or evaluation of the procedure (such as developmental delay)
- Lesions that involve portions of the head or face that will prohibit the use of VR goggles
- Severe vertigo
- Patients with nausea, vomiting, dementia, motion sickness, stroke, seizure and epilepsy and those placed in isolation (MRSA, VRE) were excluded.
- Patients who are pregnant
- Hearing or visually impaired
- Patients <18 years old
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Intervention Group: Virtual Reality
Patients will wear a virtual reality device in addition to standard lidocaine/novocaine numbing agent
|
A virtual reality device will be worn over the eyes that allows the patient to feel that they are at a quiet seaside beach.
|
|
Control Group: Music
Patients will listen to music in addition to standard lidocaine/novocaine numbing agent
|
Music of the patient's choice will be played
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective Pain
Time Frame: 1 hour
|
Subjective pain measured using the 11-point Numeric Rating Scale (NRS), which is widely employed and is a validated measure of pain (17) at the half way point and 1 minute after the procedure.The scale name is Pain Numeric Rating Scale (NRS) it is a validated scale for graphically measuring pain.
The scale range is 0-10 (11 point scale).
0 is no pain.
10 is intolerable pain.
The values on this scale will be averaged for each cohort.
|
1 hour
|
|
Blood pressure
Time Frame: 1 hour
|
Systolic and diastolic blood pressures (mmHg) at the half way point of the procedure as well as 1 minute after completion of the procedure.
Blood pressure will be measured as a surrogate measure for objective pain.
Blood pressures will be averaged for each cohort.
The data will be collected by Dynamap automated Blood pressure monitor.
|
1 hour
|
|
Heart rate
Time Frame: 1 hour
|
Heart rate at the half way point of the procedure as well as 1 minute after completion of the procedure will be measured in beats per minute using pulse oximetry.
Heart rate will be measured as a surrogate measure for objective pain.
Heart rates will be averaged for each cohort.
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety
Time Frame: 1 hour
|
Anxiety using an 11-point Numeric Rating Scale (NRS) at the half way point and 1 minute after completion of the procedure.The scale name for subjective anxiety measurement will be the Numeric Rating Scale (NRS) it is a validated scale for graphically measuring anxiety.
The scale range is 0-10 (11 point scale).
0 is no pain.
10 is intolerable pain.
The values on this scale will be averaged for each cohort.
|
1 hour
|
|
Patient Satisfaction
Time Frame: 1 hour
|
Patient satisfaction determined by the Global Rating Scale measured as 1-5 with 1 being unsatisfied and 5 being extremely satisfied.
The Global Rating Scale (GRS) for patient satisfaction is a validated scale.
These values will be averaged in each cohort.
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Karim W Sadik, MD, The Guthrie Clinic
- Principal Investigator: Crystal D Sadik, MD, The Guthrie Clinic
- Principal Investigator: Nicholas Evertson, MD, The Guthrie Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Sadik, K. , Miller, M. , Evertsen, N. , Sadik, C. and Bonatti, H. (2023) Virtual Reality in Surgery: Double Blind, Randomized Clinical Trial of Pain Control and Augmented Satisfaction. Surgical Science, 14, 456-467. doi: 10.4236/ss.2023.146050.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 22, 2019
Primary Completion (Actual)
August 1, 2020
Study Completion (Actual)
August 1, 2020
Study Registration Dates
First Submitted
April 3, 2019
First Submitted That Met QC Criteria
April 11, 2019
First Posted (Actual)
April 16, 2019
Study Record Updates
Last Update Posted (Actual)
August 22, 2024
Last Update Submitted That Met QC Criteria
August 20, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 1903-09
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.